Chapter 1: The girl Who Glowed
Nova City’s skyline sliced through the clouds like glass teeth. Beneath its sterile towers of biomedical giants, the Malik family’s two-bedroom apartment clung to the edge of the industrial zone like a barnacle. Here, sixteen-year-old Anaya Malik made beauty out of pain.
She had Ehlers-Danlos Syndrome. Her joints moved like water, dislocating unpredictably. Her skin bruised if the wind blew too hard. Her heart worked overtime, tethered by fraying collagen. But in her eyes burned the light of someone determined to live every moment louder than her body allowed.
Each morning, she greeted the sun through their rusting windowpane. “Still here,” she’d whisper. Her older brother, Arjun, would hear it from the next room, his hands soldering circuits or debugging the latest version of his bipedal assistive robot. He’d made one for her when she was ten—a clunky walker that looked like a cross between a spider and a suitcase. She called it “Stitch.”
Their bond ran deeper than blood. After their parents died in a scaffolding collapse at a construction site when Anaya was nine, Arjun became her guardian. He was barely seventeen, but genius was a poor match for grief. He dropped out of Nova Institute, turned their kitchen into a lab, and built things that whispered of futures they’d never afford.
Anaya kept smiling. Her favorite escape was imagining herself walking unaided through the central gardens of Nova City. Not with crutches, not with braces. Just… walking. Running even. There, towering above the skyline, gleamed Vyper Pharma, a fortress of steel and glass. And inside, a whisper of hope.
A new clinical trial for EDS-74. Gene therapy. Promising. Selective. “Last hope,” Anaya whispered. They made a video together to apply—Anaya smiling, Arjun narrating, both knowing they were gambling everything.
She was accepted.
The headquarters was antiseptic and beautiful, humming with wealth. Anaya was mesmerized by the polished floors and robotic arms in sterile labs. Dr. Elena Voss, lead researcher, greeted her with warmth but a distracted gaze. “Subject Fourteen,” the file read.
Three months. Three injections. And for the first time, Anaya’s shoulders held, her joints stayed put. Her bruises faded.
They danced. Arjun bought her a cake. She walked down the street without a cane. “I’m glowing,” she said.
But hope is expensive.
One day, the check-in emails stopped. Her next appointment was canceled. No explanation. When Arjun called, they stonewalled him. Then the leak happened.
An internal memo from CEO Marcus Hale surfaced. “Redirect resources to Project Bloom. EDS-74 trial ROI insufficient.” Bloom was an anti-aging cream line for the elite.
Anaya’s health collapsed.
Arjun sold his entire lab to pay for old medications. They were ineffective. She was taken to Nova General—public, underfunded, overwhelmed. The night she died, her heart failed from a cheap, outdated beta-blocker. Arjun was holding her hand. She smiled. “Still here,” she whispered.
She wasn’t.
